Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
NCT03835013
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Cardiovascular Diseases
Interventions
DRUG:
Saline 0.9%
DRUG:
Glucagon (25ng/kg/min)
DRUG:
Glucagon (50ng/kg/min)
DRUG:
Exenatide
Sponsor
Cambridge University Hospitals NHS Foundation Trust